Kit Carson County Memorial Hospital | |
286 16th St, Burlington, Colorado 80807 | |
(719) 346-5311 | |
Not Available |
Name | Kit Carson County Memorial Hospital |
---|---|
Type | Critical Access Hospital |
Location | 286 16th St, Burlington, Colorado |
Ownership | Government - Hospital District or Authority |
Emergency Services | Yes |
Medicare ID (CCN) | 061313 |
NPI Number | 1184711475 |
Organization Name | KIT CARSON COUNTY HEALTH SERVICES DISTRICT |
Doing Business As | KIT CARSON COUNTY MEMORIAL HOSPITAL |
Address | 286 16th Street, Burlington, CO 80807 |
Hospital Type | General Acute Care Hospital - Critical Access |
Phone Number | 719-346-5311 |
News Archive
On Wednesday, March 21, the Congressional Brain Injury Task Force brings representatives from the brain injury community to Capitol Hill for Brain Injury Awareness (BIA) Day. The day starts with the BIA Fair, where attendees share information on policy issues, research, diagnosis and screening and care and rehabilitation. The afternoon features a briefing on "The Impact of Brain Injury: Any Time, Any One, Any Age."
A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumors, may give clues to how cancers evade the immune system, according to a study part-funded by Cancer Research UK and published in Cancer Cell today.
A new study in Biomedical Instrumentation & Technology reports on the findings of a study that is the first phase of a project to develop benchmarks to measure clinical engineering activities.
Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).
Biologics-na-ve Juvenile Idiopathic Arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an increased frequency of cancer in those receiving the biologic etanercept, however, results were deemed not statistically significant by researchers.
› Verified 9 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
On Wednesday, March 21, the Congressional Brain Injury Task Force brings representatives from the brain injury community to Capitol Hill for Brain Injury Awareness (BIA) Day. The day starts with the BIA Fair, where attendees share information on policy issues, research, diagnosis and screening and care and rehabilitation. The afternoon features a briefing on "The Impact of Brain Injury: Any Time, Any One, Any Age."
A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumors, may give clues to how cancers evade the immune system, according to a study part-funded by Cancer Research UK and published in Cancer Cell today.
A new study in Biomedical Instrumentation & Technology reports on the findings of a study that is the first phase of a project to develop benchmarks to measure clinical engineering activities.
Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).
Biologics-na-ve Juvenile Idiopathic Arthritis patients may have an increased risk of cancer compared with the general Swedish population, according to research presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy. Results of an additional study, which researched a small cohort of patients showed an increased frequency of cancer in those receiving the biologic etanercept, however, results were deemed not statistically significant by researchers.
› Verified 9 days ago
Kit Carson County Memorial Hospital Critical Access Hospital Location: 286 16th St, Burlington, Colorado 80807 Phone: (719) 346-5311 |